Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$346,351
-$34,913 QoQ
Shares Held
2,210
-11.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,054
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trek Financial, LLC holds $22,596,486 across 11 Drug Manufacturers - General names. NVS ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,151 | $9,943,179 | |
| 2 | LLY |
ELI LILLY & Co
|
3,679 | $4,412,703 | |
| 3 | AMGN |
Amgen Inc
|
7,005 | $2,536,650 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,440 | $2,077,029 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 6 | ABBV |
AbbVie Inc.
|
3,156 | $794,175 | |
| 7 | NVO |
Novo Nordisk A S
|
10,744 | $515,067 | |
| 8 | NVS |
Novartis AG
This page
|
2,210 | $346,351 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,351 | 2,210 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $381,264 | 2,496 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $286,493 | 2,078 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||